Prion-protein-interacting amyloid-β oligomers of high molecular weight are tightly correlated with memory impairment in multiple Alzheimer mouse models

Mikhail A. Kostylev, Adam C. Kaufman, Haakon B. Nygaard, Pujan Patel, Laura T. Haas, Erik C. Gunther, Alexander Vortmeyer, Stephen M. Strittmatter

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Alzheimer disease (AD) is characterized by amyloid-β accumulation, with soluble oligomers (Aβo) being the most synaptotoxic. However, the multivalent and unstable nature of Aβo limits molecular characterization and hinders research reproducibility. Here, we characterized multiple Aβo forms throughout the life span of various AD mice and in post-mortem human brain. Aβo exists in several populations, where prion protein (PrPC)-interacting Aβo is a high molecular weight Aβ assembly present in multiple mice and humans with AD. Levels of PrPC-interacting Aβo match closely with mouse memory and are equal or superior to other Aβ measures in predicting behavioral impairment. However, Aβo metrics vary considerably between mouse strains. Deleting PrPC expression in mice with relatively low PrPC -interacting Aβo (Tg2576) results in partial rescue of cognitive performance as opposed to complete recovery in animals with a high percentage of PrPC-interacting Aβo (APP/PSEN1). These findings highlight the relative contributions and interplay of Aβo forms in AD.

Original languageEnglish (US)
Pages (from-to)17415-17438
Number of pages24
JournalJournal of Biological Chemistry
Volume290
Issue number28
DOIs
StatePublished - Jul 10 2015
Externally publishedYes

Fingerprint

Oligomers
Amyloid
Molecular Weight
Molecular weight
Alzheimer Disease
Data storage equipment
PrPC Proteins
Brain
Animals
Recovery
Prions
Prion Proteins
Research
Population

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Prion-protein-interacting amyloid-β oligomers of high molecular weight are tightly correlated with memory impairment in multiple Alzheimer mouse models. / Kostylev, Mikhail A.; Kaufman, Adam C.; Nygaard, Haakon B.; Patel, Pujan; Haas, Laura T.; Gunther, Erik C.; Vortmeyer, Alexander; Strittmatter, Stephen M.

In: Journal of Biological Chemistry, Vol. 290, No. 28, 10.07.2015, p. 17415-17438.

Research output: Contribution to journalArticle

Kostylev, Mikhail A. ; Kaufman, Adam C. ; Nygaard, Haakon B. ; Patel, Pujan ; Haas, Laura T. ; Gunther, Erik C. ; Vortmeyer, Alexander ; Strittmatter, Stephen M. / Prion-protein-interacting amyloid-β oligomers of high molecular weight are tightly correlated with memory impairment in multiple Alzheimer mouse models. In: Journal of Biological Chemistry. 2015 ; Vol. 290, No. 28. pp. 17415-17438.
@article{12f574dba7d84a0e9d1735cbf0d39941,
title = "Prion-protein-interacting amyloid-β oligomers of high molecular weight are tightly correlated with memory impairment in multiple Alzheimer mouse models",
abstract = "Alzheimer disease (AD) is characterized by amyloid-β accumulation, with soluble oligomers (Aβo) being the most synaptotoxic. However, the multivalent and unstable nature of Aβo limits molecular characterization and hinders research reproducibility. Here, we characterized multiple Aβo forms throughout the life span of various AD mice and in post-mortem human brain. Aβo exists in several populations, where prion protein (PrPC)-interacting Aβo is a high molecular weight Aβ assembly present in multiple mice and humans with AD. Levels of PrPC-interacting Aβo match closely with mouse memory and are equal or superior to other Aβ measures in predicting behavioral impairment. However, Aβo metrics vary considerably between mouse strains. Deleting PrPC expression in mice with relatively low PrPC -interacting Aβo (Tg2576) results in partial rescue of cognitive performance as opposed to complete recovery in animals with a high percentage of PrPC-interacting Aβo (APP/PSEN1). These findings highlight the relative contributions and interplay of Aβo forms in AD.",
author = "Kostylev, {Mikhail A.} and Kaufman, {Adam C.} and Nygaard, {Haakon B.} and Pujan Patel and Haas, {Laura T.} and Gunther, {Erik C.} and Alexander Vortmeyer and Strittmatter, {Stephen M.}",
year = "2015",
month = "7",
day = "10",
doi = "10.1074/jbc.M115.643577",
language = "English (US)",
volume = "290",
pages = "17415--17438",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "28",

}

TY - JOUR

T1 - Prion-protein-interacting amyloid-β oligomers of high molecular weight are tightly correlated with memory impairment in multiple Alzheimer mouse models

AU - Kostylev, Mikhail A.

AU - Kaufman, Adam C.

AU - Nygaard, Haakon B.

AU - Patel, Pujan

AU - Haas, Laura T.

AU - Gunther, Erik C.

AU - Vortmeyer, Alexander

AU - Strittmatter, Stephen M.

PY - 2015/7/10

Y1 - 2015/7/10

N2 - Alzheimer disease (AD) is characterized by amyloid-β accumulation, with soluble oligomers (Aβo) being the most synaptotoxic. However, the multivalent and unstable nature of Aβo limits molecular characterization and hinders research reproducibility. Here, we characterized multiple Aβo forms throughout the life span of various AD mice and in post-mortem human brain. Aβo exists in several populations, where prion protein (PrPC)-interacting Aβo is a high molecular weight Aβ assembly present in multiple mice and humans with AD. Levels of PrPC-interacting Aβo match closely with mouse memory and are equal or superior to other Aβ measures in predicting behavioral impairment. However, Aβo metrics vary considerably between mouse strains. Deleting PrPC expression in mice with relatively low PrPC -interacting Aβo (Tg2576) results in partial rescue of cognitive performance as opposed to complete recovery in animals with a high percentage of PrPC-interacting Aβo (APP/PSEN1). These findings highlight the relative contributions and interplay of Aβo forms in AD.

AB - Alzheimer disease (AD) is characterized by amyloid-β accumulation, with soluble oligomers (Aβo) being the most synaptotoxic. However, the multivalent and unstable nature of Aβo limits molecular characterization and hinders research reproducibility. Here, we characterized multiple Aβo forms throughout the life span of various AD mice and in post-mortem human brain. Aβo exists in several populations, where prion protein (PrPC)-interacting Aβo is a high molecular weight Aβ assembly present in multiple mice and humans with AD. Levels of PrPC-interacting Aβo match closely with mouse memory and are equal or superior to other Aβ measures in predicting behavioral impairment. However, Aβo metrics vary considerably between mouse strains. Deleting PrPC expression in mice with relatively low PrPC -interacting Aβo (Tg2576) results in partial rescue of cognitive performance as opposed to complete recovery in animals with a high percentage of PrPC-interacting Aβo (APP/PSEN1). These findings highlight the relative contributions and interplay of Aβo forms in AD.

UR - http://www.scopus.com/inward/record.url?scp=84940063508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940063508&partnerID=8YFLogxK

U2 - 10.1074/jbc.M115.643577

DO - 10.1074/jbc.M115.643577

M3 - Article

C2 - 26018073

AN - SCOPUS:84940063508

VL - 290

SP - 17415

EP - 17438

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 28

ER -